{
    "organizations": [],
    "uuid": "5d04e3356d3c112c555741257f496b049ec5c484",
    "author": "",
    "url": "https://www.reuters.com/article/brief-crispr-therapeutics-commences-publ/brief-crispr-therapeutics-commences-public-offering-of-100-mln-common-shares-idUSASB0BZJ5",
    "ord_in_thread": 0,
    "title": "BRIEF-Crispr Therapeutics ‍Commences Public Offering Of $100 Mln Common Shares​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 30 AM / Updated 23 minutes ago BRIEF-Crispr Therapeutics ‍Commences Public Offering Of $100 Mln Common Shares​ Reuters Staff \nJan 3 (Reuters) - Crispr Therapeutics Ag: \n* CRISPR THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES \n* CRISPR THERAPEUTICS AG - ‍COMMENCING AN UNDERWRITTEN PUBLIC OFFERING OF $100 MILLION OF ITS COMMON SHARES​ Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T13:30:00.000+02:00",
    "crawled": "2018-01-03T13:57:48.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "public",
        "offering",
        "mln",
        "common",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "crispr",
        "therapeutic",
        "ag",
        "crispr",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "share",
        "crispr",
        "therapeutic",
        "ag",
        "underwritten",
        "public",
        "offering",
        "million",
        "common",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}